Tilray Quarterly Income Statements Chart
Quarterly
|
Annual
Tilray Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 | 2022-11-30 | 2022-08-31 | 2022-05-31 | 2022-02-28 | 2021-11-30 | 2021-08-31 | 2021-05-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net revenue | 185,780,000 | 210,950,000 | 200,044,000 | 229,882,000 | 188,340,000 | 193,771,000 | 176,949,000 | 184,188,000 | 145,589,000 | 144,136,000 | 153,211,000 | 153,325,000 | 151,871,000 | 155,153,000 | 168,023,000 | |||||||||||||
yoy | -1.36% | 8.87% | 13.05% | 24.81% | 29.36% | 34.44% | 15.49% | 20.13% | -4.14% | -7.10% | -8.82% | |||||||||||||||||
qoq | -11.93% | 5.45% | -12.98% | 22.06% | -2.80% | 9.51% | -3.93% | 26.51% | 1.01% | -5.92% | -0.07% | 0.96% | -2.12% | -7.66% | ||||||||||||||
cost of goods sold | 133,769,000 | 149,730,000 | 140,338,000 | 147,532,000 | 138,944,000 | 146,362,000 | 132,753,000 | 117,025,000 | 157,288,000 | 104,012,000 | 104,597,000 | 160,058,000 | 112,042,000 | 122,387,000 | 117,068,000 | |||||||||||||
gross profit | 52,011,000 | 61,220,000 | 59,706,000 | 82,350,000 | 49,396,000 | 47,409,000 | 44,196,000 | 67,163,000 | -11,699,000 | 40,124,000 | 48,614,000 | -6,733,000 | 39,829,000 | 32,766,000 | 50,955,000 | 109,679,000 | 13,503,000 | 15,465,000 | 3,739,000 | -5,419,000 | 10,870,000 | -57,007,000 | 15,853,000 | 12,273,000 | ||||
yoy | 5.29% | 29.13% | 35.09% | 22.61% | -522.22% | 18.16% | -9.09% | -1097.52% | -129.37% | 22.46% | -4.59% | -106.14% | 194.96% | 111.87% | 1262.80% | -2123.97% | 24.22% | -127.13% | -76.41% | -144.15% | ||||||||
qoq | -15.04% | 2.54% | -27.50% | 66.71% | 4.19% | 7.27% | -34.20% | -674.09% | -129.16% | -17.46% | -822.03% | -116.90% | 21.56% | -35.70% | -53.54% | 712.26% | -12.69% | 313.61% | -169.00% | -149.85% | -119.07% | -459.60% | 29.17% | |||||
gross margin % | 28.00% | 29.02% | 29.85% | 35.82% | 26.23% | 24.47% | 24.98% | 36.46% | -8.04% | 27.84% | 31.73% | -4.39% | 26.23% | 21.12% | 30.33% | |||||||||||||
operating expenses: | ||||||||||||||||||||||||||||
general and administrative | 39,246,000 | 45,997,000 | 44,113,000 | 43,589,000 | 39,940,000 | 43,313,000 | 40,516,000 | 47,774,000 | 38,999,000 | 41,672,000 | 40,508,000 | 41,400,000 | 38,445,000 | 33,469,000 | 49,487,000 | |||||||||||||
selling | 13,905,000 | 16,162,000 | 11,690,000 | 12,796,000 | 9,995,000 | 7,583,000 | 6,859,000 | 9,048,000 | 6,452,000 | 9,669,000 | 9,671,000 | 9,643,000 | 8,641,000 | 9,210,000 | 7,432,000 | |||||||||||||
amortization | 23,182,000 | 22,927,000 | 21,804,000 | 19,052,000 | 21,558,000 | 21,917,000 | 22,225,000 | 21,617,000 | 23,518,000 | 23,995,000 | 24,359,000 | 30,846,000 | 24,590,000 | 29,016,000 | 30,739,000 | |||||||||||||
marketing and promotion | 6,793,000 | 9,720,000 | 11,566,000 | 12,999,000 | 11,191,000 | 9,208,000 | 8,535,000 | 7,800,000 | 7,354,000 | 8,535,000 | 7,248,000 | 10,771,000 | 7,578,000 | 7,120,000 | 5,465,000 | |||||||||||||
research and development | 85,000 | 60,000 | 105,000 | 394,000 | 106,000 | 56,000 | 79,000 | 180,000 | 171,000 | 165,000 | 166,000 | 54,000 | 164,000 | 515,000 | 785,000 | |||||||||||||
change in fair value of contingent consideration | 1,000,000 | -5,983,000 | 300,000 | -11,107,000 | 292,000 | 352,000 | 211,000 | -15,585,000 | -29,065,000 | |||||||||||||||||||
impairments | 699,235,000 | -181,376,000 | 1,115,376,000 | |||||||||||||||||||||||||
other than temporary change in fair value of convertible notes receivable | 20,000,000 | 42,681,000 | ||||||||||||||||||||||||||
litigation costs, net of recoveries | 2,758,000 | 901,000 | 1,595,000 | -188,000 | 3,363,000 | 3,042,000 | ||||||||||||||||||||||
restructuring costs | 6,133,000 | 6,869,000 | 4,247,000 | 6,833,000 | 5,178,000 | 2,655,000 | 915,000 | -1,482,000 | 2,663,000 | |||||||||||||||||||
transaction costs (income) | 605,000 | 802,000 | 1,156,000 | |||||||||||||||||||||||||
total operating expenses | 811,942,000 | 103,438,000 | 96,276,000 | 98,876,000 | 131,494,000 | 89,168,000 | 78,558,000 | 157,143,000 | 1,195,037,000 | 91,915,000 | 69,792,000 | 460,690,000 | 59,591,000 | 87,450,000 | 119,487,000 | |||||||||||||
operating income | -759,931,000 | -42,218,000 | -36,570,000 | -16,526,000 | -82,098,000 | -41,759,000 | -34,362,000 | -89,980,000 | -1,206,736,000 | -51,791,000 | -21,178,000 | -467,423,000 | -19,762,000 | -54,684,000 | -68,532,000 | -58,861,000 | -73,310,000 | -21,282,000 | -32,772,000 | -75,820,000 | -71,250,000 | -218,038,000 | -23,302,000 | -32,520,000 | -27,874,000 | -22,907,000 | -20,012,000 | -10,990,000 |
yoy | 825.64% | 1.10% | 6.43% | -81.63% | -93.20% | -19.37% | 62.25% | -80.75% | 6006.35% | -5.29% | -69.10% | 694.11% | -73.04% | 156.95% | 109.12% | -22.37% | 2.89% | -90.24% | 40.64% | 133.15% | 155.61% | 851.84% | 16.44% | 195.91% | ||||
qoq | 1700.02% | 15.44% | 121.29% | -79.87% | 96.60% | 21.53% | -61.81% | -92.54% | 2230.01% | 144.55% | -95.47% | 2265.26% | -63.86% | -20.21% | 16.43% | -19.71% | 244.47% | -35.06% | -56.78% | 6.41% | -67.32% | 835.71% | -28.35% | 16.67% | 21.68% | 14.47% | 82.09% | |
operating margin % | -409.05% | -20.01% | -18.28% | -7.19% | -43.59% | -21.55% | -19.42% | -48.85% | -828.86% | -35.93% | -13.82% | -304.86% | -13.01% | -35.25% | -40.79% | |||||||||||||
interest expense | -8,378,000 | -7,766,000 | -9,842,000 | -9,456,000 | -8,517,000 | -8,625,000 | -9,835,000 | -5,027,000 | -1,040,000 | -3,107,000 | -4,413,000 | -5,522,000 | -2,312,000 | -9,940,000 | 6,504,500 | 8,687,000 | 8,586,000 | 8,745,000 | 7,717,000 | 480,000 | ||||||||
non-operating income | -24,022,000 | -33,255,000 | 12,646,000 | -17,022,000 | -17,239,000 | 821,000 | -4,402,000 | -16,680,000 | 1,213,000 | -18,450,000 | -32,992,000 | 11,342,000 | 72,719,000 | 64,750,000 | 48,860,000 | |||||||||||||
income before income taxes | -792,331,000 | -83,239,000 | -33,766,000 | -43,004,000 | -107,854,000 | -49,563,000 | -48,599,000 | -111,687,000 | -1,206,563,000 | -73,348,000 | -58,583,000 | -461,603,000 | 50,645,000 | 126,000 | -29,842,000 | -3,774,000 | -341,212,000 | -5,043,000 | -1,939,000 | -84,601,000 | -185,094,000 | -225,002,000 | -33,051,000 | -37,248,000 | -34,318,000 | -35,547,000 | -18,675,000 | -12,770,000 |
income tax expense (recovery) | 1,203,000 | 2,036,000 | ||||||||||||||||||||||||||
net income | -793,534,000 | -85,275,000 | -34,652,000 | -15,375,000 | -104,983,000 | -46,183,000 | -55,863,000 | -119,819,000 | -1,195,752,000 | -61,635,000 | -65,794,000 | -457,800,000 | 52,475,000 | 5,797,000 | -34,604,000 | 4,941,000 | -340,955,000 | -2,949,000 | -2,316,000 | -81,687,000 | -184,123,000 | -220,137,000 | -35,678,000 | -35,053,000 | -30,301,000 | -31,009,000 | -18,699,000 | -12,833,000 |
yoy | 655.87% | 84.65% | -37.97% | -87.17% | -91.22% | -25.07% | -15.09% | -73.83% | -2378.71% | -1163.22% | 90.13% | -9365.33% | -115.39% | -296.58% | 1394.13% | -106.05% | 85.18% | -98.66% | -93.51% | 133.04% | 507.65% | 609.91% | 90.80% | 173.15% | ||||
qoq | 830.56% | 146.09% | 125.38% | -85.35% | 127.32% | -17.33% | -53.38% | -89.98% | 1840.05% | -6.32% | -85.63% | -972.42% | 805.21% | -116.75% | -800.34% | -101.45% | 11461.72% | 27.33% | -97.16% | -55.63% | -16.36% | 517.01% | 1.78% | 15.68% | -2.28% | 65.83% | 45.71% | |
net income margin % | -427.14% | -40.42% | -17.32% | -6.69% | -55.74% | -23.83% | -31.57% | -65.05% | -821.32% | -42.76% | -42.94% | -298.58% | 34.55% | 3.74% | -20.59% | |||||||||||||
total net income attributable to: | ||||||||||||||||||||||||||||
stockholders of tilray brands, inc. | -789,436,000 | -85,342,000 | -39,165,000 | -31,747,000 | -92,701,000 | -49,008,000 | -71,525,000 | -138,713,000 | -1,170,998,000 | -69,463,000 | -73,482,000 | -478,141,000 | 43,190,000 | |||||||||||||||
non-controlling interests | -4,098,000 | 67,000 | 4,513,000 | 16,372,000 | -12,282,000 | 2,825,000 | 15,662,000 | 18,894,000 | -24,754,000 | 7,828,000 | 7,688,000 | 20,341,000 | 9,285,000 | 5,998,000 | 7,045,000 | |||||||||||||
other comprehensive gain, net of tax | ||||||||||||||||||||||||||||
foreign currency translation gain | -5,389,000 | -8,966,000 | 4,160,000 | -595,000 | -4,696,000 | 5,203,000 | 3,209,000 | -5,034,000 | 6,390,000 | -10,665,000 | 18,498,000 | -32,367,000 | -100,772,000 | 156,645,247 | 3,753 | 5,687 | 2,265 | 7,184 | 2,924 | 124 | 450 | 86 | ||||||
total other comprehensive gain, net of tax | -5,389,000 | -8,966,000 | 4,160,000 | -595,000 | -4,696,000 | -830,500 | 101,735,000 | |||||||||||||||||||||
comprehensive loss | -798,923,000 | -94,241,000 | -30,492,000 | -15,970,000 | -109,679,000 | -40,980,000 | -52,654,000 | -103,875,000 | -128,611,000 | -42,875,000 | -136,025,000 | -84,300.5 | -337,202 | -74,468 | -200,830 | -212,915 | -40,842 | -32,891 | -29,368 | -31,650 | -18,249 | -12,747 | ||||||
total comprehensive income attributable to: | ||||||||||||||||||||||||||||
weighted-average number of common shares - basic | 908,342,792,000 | 864,974,563,000 | 875,444,828,000 | 742,649,477,000 | 754,439,331,000 | 730,769,132,000 | 691,189,382,000 | 617,982,589,000 | 615,534,670,000 | 611,711,377,000 | 575,301,374,000 | 481,219,130,000 | 485,668,750,000 | 460,254,275,000 | 449,397,822,000 | 269,549,852,000 | ||||||||||||
weighted-average number of common shares - diluted | 908,342,792,000 | 864,974,563,000 | 875,444,828,000 | 742,649,477,000 | 754,439,331,000 | 730,769,132,000 | 691,189,382,000 | 617,982,589,000 | 615,534,670,000 | 611,711,377,000 | 575,301,374,000 | 481,219,130,000 | 488,546,790,000 | 460,254,275,000 | 449,397,822,000 | 269,549,852,000 | ||||||||||||
net income per share | -0.87 | -0.1 | -0.04 | -0.04 | -0.12 | -0.07 | -0.1 | -0.15 | -1.9 | -0.11 | -0.13 | -0.9 | 0.09 | 0 | -0.503 | -2.01 | 0.08 | -0.02 | -0.65 | -1.73 | -2.16 | -0.36 | -0.36 | -0.32 | -0.43 | -0.2 | ||
income tax expense | 886,000 | 7,264,000 | 21,750 | 24,000 | -63,000 | |||||||||||||||||||||||
transaction costs | 3,265,250 | 3,465,000 | -11,198,000 | 9,238,000 | 8,120,000 | 25,579,000 | ||||||||||||||||||||||
income tax (recovery) expense | -27,629,000 | -2,871,000 | -3,380,000 | |||||||||||||||||||||||||
unrealized gain on convertible notes receivable | 95,345,000 | |||||||||||||||||||||||||||
transaction (income) costs | 1,094,000 | 8,502,000 | -970,500 | 5,382,000 | 5,064,000 | -12,816,000 | ||||||||||||||||||||||
total other comprehensive loss, net of tax | 5,203,000 | 3,209,000 | -42,240,000 | -62,817,000 | ||||||||||||||||||||||||
litigation costs | 2,034,000 | 2,815,000 | 445,000 | |||||||||||||||||||||||||
litigation (recovery) costs | 1,465,000 | -5,230,000 | ||||||||||||||||||||||||||
income taxes (benefit) expense | -3,828,250 | -10,811,000 | -11,713,000 | |||||||||||||||||||||||||
comprehensive income | -331,625,750 | -1,094,017,000 | -36,805,750 | 31,677,000 | -68,788.5 | 142 | ||||||||||||||||||||||
other comprehensive loss, net of tax | ||||||||||||||||||||||||||||
foreign currency translation loss | -24,597,000 | -60,292,000 | -16,633 | -603.5 | -4,863 | -475 | ||||||||||||||||||||||
unrealized loss on convertible notes receivable | -17,643,000 | -2,525,000 | -70,779,000 | -52,000 | 52,000 | -649,000 | ||||||||||||||||||||||
income taxes | 7,211,000 | -3,803,000 | -1,830,000 | -5,671,000 | 4,762,000 | |||||||||||||||||||||||
other comprehensive income, net of tax | ||||||||||||||||||||||||||||
change in fair value of long-term investments | -13,900,250 | -39,244,000 | -16,357,000 | |||||||||||||||||||||||||
total other comprehensive income, net of tax | -25,843,000 | -20,798,000 | -48,672,000 | -101,421,000 | ||||||||||||||||||||||||
shareholders of tilray inc. | -201,000 | -41,649,000 | ||||||||||||||||||||||||||
finance expense | -10,170,000 | |||||||||||||||||||||||||||
loss per share - basic | -0.08 | |||||||||||||||||||||||||||
loss per share - diluted | -0.08 | |||||||||||||||||||||||||||
revenue | 12,005,250 | 48,021,000 | 56,560,000 | 51,406,000 | 50,414,000 | 52,102,000 | 46,936,000 | 51,101,000 | 45,904,000 | 23,038,000 | 15,531,000 | 10,047,000 | 9,744,000 | |||||||||||||||
cost of sales | 8,629,500 | 34,518,000 | 21,633,000 | 35,248,000 | 33,631,000 | 17,653,000 | 12,397,000 | 6,979,000 | 5,567,000 | |||||||||||||||||||
general and administrative expenses | 6,396,750 | 25,587,000 | 36,853,000 | 12,665,000 | 14,444,000 | 17,776,000 | 16,465,000 | 12,797,000 | 13,777,000 | 7,540,000 | 5,622,000 | |||||||||||||||||
sales and marketing expenses | 2,434,750 | 9,739,000 | 13,957,000 | 10,000,000 | 12,833,000 | 17,876,000 | 14,366,000 | 7,821,000 | 6,305,000 | 3,493,000 | 3,305,000 | |||||||||||||||||
research and development expenses | 300,500 | 1,202,000 | 1,580,000 | 921,000 | 652,000 | 1,258,000 | 1,528,000 | 1,048,000 | 1,848,000 | 802,000 | 639,000 | |||||||||||||||||
depreciation and amortization expenses | 874,500 | 3,498,000 | 3,369,000 | 3,425,000 | 3,337,000 | 3,591,000 | ||||||||||||||||||||||
impairment of assets | 2,904,000 | 28,371,000 | 29,839,000 | |||||||||||||||||||||||||
income from equity method investments | 446,750 | 1,787,000 | 1,488,000 | 1,420,000 | 1,327,000 | 1,748,000 | 2,667,000 | 1,837,000 | ||||||||||||||||||||
litigation settlement | 11,250,000 | 45,000,000 | ||||||||||||||||||||||||||
foreign exchange (gain) loss | -174,750 | -699,000 | -18,593,000 | -9,319,000 | -13,326,000 | -1,611,000 | ||||||||||||||||||||||
change in fair value of warrant liability | 65,800,250 | 263,201,000 | 49,011,000 | -31,913,000 | 11,210,000 | 71,978,000 | ||||||||||||||||||||||
interest expenses | 1,729,000 | 6,916,000 | 9,072,000 | 10,437,000 | 10,564,000 | 9,146,000 | ||||||||||||||||||||||
other incomes | -379,000 | -1,516,000 | ||||||||||||||||||||||||||
deferred income tax recoveries | -158,750 | -635,000 | -2,875,000 | -1,272,000 | ||||||||||||||||||||||||
current income tax expenses | 94,500 | 378,000 | 126,250 | 243,000 | -39,000 | 301,000 | ||||||||||||||||||||||
weighted-average shares used for eps calculation | 169,489,223 | 126,041,710 | 129,100,909 | 124,763,445 | 106,463,352 | 100,455,677 | 98,130,507 | 97,231,839 | 94,875,351 | 83,009,656 | ||||||||||||||||||
unrealized loss on investments | ||||||||||||||||||||||||||||
other comprehensive loss | 938.25 | 3,753 | -16,707 | -517.25 | -5,164 | |||||||||||||||||||||||
product costs | 27,154,000 | 34,224,000 | 37,204,000 | 37,188,000 | ||||||||||||||||||||||||
inventory valuation adjustments | 9,029,000 | 13,443,000 | 18,629,000 | 4,044,000 | ||||||||||||||||||||||||
stock-based compensation expenses | 5,851,000 | 8,080,000 | 7,647,000 | 7,677,000 | ||||||||||||||||||||||||
acquisition-related expenses (income) | ||||||||||||||||||||||||||||
finance income from abg | ||||||||||||||||||||||||||||
other income | 1,236,000 | -38,000 | 333,000 | 4,651,000 | 3,160,000 | -1,313,000 | -2,035,000 | -2,345,000 | -1,398,000 | -225,000 | -76,000 | |||||||||||||||||
deferred income tax expenses | -1,003,250 | 134,000 | ||||||||||||||||||||||||||
unrealized gain on available-for-sale debt securities | 38.5 | 193 | 35 | -74 | ||||||||||||||||||||||||
other comprehensive income | 5,516 | 2,458 | 7,219 | 2,162 | 933 | |||||||||||||||||||||||
acquisition-related expenses | 1,790,000 | 2,355,000 | ||||||||||||||||||||||||||
foreign exchange loss | 28,069,000 | 179,000 | ||||||||||||||||||||||||||
general and administrative expense | 12,310,000 | 19,978,000 | ||||||||||||||||||||||||||
sales and marketing expense | 9,790,250 | 16,974,000 | ||||||||||||||||||||||||||
depreciation and amortization expense | 1,859,500 | 3,190,000 | 2,385,000 | 1,863,000 | ||||||||||||||||||||||||
stock-based compensation expense | 5,301,500 | 8,315,000 | 7,585,000 | 5,306,000 | 4,111,000 | 11,245,000 | 5,601,000 | |||||||||||||||||||||
research and development expense | 1,222,750 | 2,315,000 | ||||||||||||||||||||||||||
acquisition-related income | -1,649,500 | -13,454,000 | ||||||||||||||||||||||||||
foreign exchange gain | 288,250 | 2,585,000 | 6,321,000 | -1,592,000 | 1,359,000 | |||||||||||||||||||||||
finance income from abg profit participation arrangement | -139,250 | -210,000 | -212,000 | -135,000 | ||||||||||||||||||||||||
deferred income tax expense | -996,750 | 2,432,000 | ||||||||||||||||||||||||||
current income tax expense | 100,500 | 195,000 | 447,000 | |||||||||||||||||||||||||
unrealized gain on cash equivalents and investments | 86.25 | -301 | -762 | 1,408 | ||||||||||||||||||||||||
acquisition and integration expenses | 2,464,000 | 4,424,000 | ||||||||||||||||||||||||||
deferred income tax recovery | -2,642,000 | -3,777,000 | ||||||||||||||||||||||||||
gross margin | 5,385,000 | 3,134,000 | 3,068,000 | 4,177,000 | ||||||||||||||||||||||||
current income tax recovery | -240,000 | |||||||||||||||||||||||||||
shares used in computation of net income per share - basic and diluted | 23,286,010.5 | 93,144,042 | ||||||||||||||||||||||||||
interest income | 497,000 | |||||||||||||||||||||||||||
basic and diluted net income per share | -0.17 | |||||||||||||||||||||||||||
shares used in compilation of net income per share, basic and diluted | 75,000,000 |
We provide you with 20 years income statements for Tilray stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Tilray stock. Explore the full financial landscape of Tilray stock with our expertly curated income statements.
The information provided in this report about Tilray stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.